F. Laberge

发表

Probability of cancer in pulmonary nodules detected on first screening CT.

S. Lam, C. Berg, A. Tremblay, 2013, The New England journal of medicine.

Influence of lung volume on collateral resistance during methacholine‐induced bronchospasm

F. Sériès, M. Laviolette, Y. Cormier, 1994, European journal of clinical investigation.

Comparative Efficacy and Safety of Controlled‐Release Morphine Suppositories and Tablets in Cancer Pain

D. Moulin, F. Laberge, L. Provencher, 1998, Journal of clinical pharmacology.

A "Tracheal Bridge": An Unusual Presentation of Posttracheostomy Tracheal Stenoses.

F. Laberge, J. Guinde, M. Fortin, 2020, Journal of bronchology & interventional pulmonology.

Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital.

Y. Lacasse, F. Laberge, S. Martin, 2008, Canadian respiratory journal.

Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience

K. Gelmon, F. Shepherd, J. Bérille, 1998, Investigational New Drugs.

The Bone Scan Flare Phenomenon in Non–Small-Cell Lung Cancer

Y. Cormier, F. Laberge, J. Guimond, 2002, Clinical nuclear medicine.

Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium.

L. Boulet, J. Malo, D. Cockcroft, 1990, Respiratory medicine.

A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group.

L. Boulet, D. Cockcroft, A. Cartier, 1990, The Journal of allergy and clinical immunology.

Immunotherapy and pseudoprogression in lung adenocarcinoma

Y. Lacasse, L. Tremblay, S. Martel, 2017 .

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.

L. Seymour, K. Ding, F. Shepherd, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Occupational asthma to fish

L. Boulet, F. Laberge, 2014, Occupational and Environmental Medicine.

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

F. Shepherd, D. Walde, L. Yelle, 1995, Supportive Care in Cancer.

Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.

B. O'brien, T. Vandenberg, J. Latreille, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

E. Eisenhauer, R. Wierzbicki, Y. Cormier, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

237 What is standard therapy for stage IIIA non-small cell lung cancer (NSCLC)?: A randomized trial of combination chemotherapy (C) and surgery (S) versus radiotherapy (RT) alone

F. Shepherd, J. Deslauriers, G. Darling, 1997 .

A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy.

F. Maltais, M. Laviolette, F. Laberge, 1996, Chest.

Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1

H. Fritsche, M. Valdivieso, D. Carr, 1987, Cancer.

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.

M. Stockler, L. Seymour, K. Ding, 2014, European journal of cancer.

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

S. Lam, D. Sin, A. Tremblay, 2017, The Lancet. Oncology.

Wait times for diagnosis and treatment of lung cancer: a single-centre experience.

Y. Lacasse, S. Simard, L. Tremblay, 2017, Current oncology.

Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial.

R. Whittom, J. Latreille, V. Hirsh, 2004, Lung cancer.

A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.

D. Osoba, J. Pater, J. Latreille, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.

D. Johnston, D. Osoba, F. Shepherd, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

L. Seymour, G. Nicholas, T. Reiman, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.

D. Osoba, A. Willan, C. Erlichman, 1991, Journal of the National Cancer Institute.

A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.

D. Osoba, J. Pater, J. Latreille, 1992, European journal of cancer.

Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.

G. Batist, J. Latreille, F. Laberge, 2003, Clinical lung cancer.

Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24.

L. Seymour, K. Ding, F. Shepherd, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.

A. Bezjak, L. Seymour, F. Shepherd, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endobronchial Ultrasound for Staging of the Radiologically Normal Mediastinum: Should We Individualize Our Approach?

S. Martel, F. Laberge, P. Ugalde, 2020, Annals of the American Thoracic Society.

Plasma pro-surfactant protein B and lung function decline in smokers

S. Lam, D. Sin, A. Tremblay, 2015, European Respiratory Journal.

Randomized Trial Comparing Patient Comfort Between the Oral and Nasal Insertion Routes for Linear Endobronchial Ultrasound

S. Martel, F. Laberge, N. Lampron, 2016, Journal of bronchology & interventional pulmonology.

S. Lam, A. Tremblay, M. Tsao, 2019, BMJ Open.

Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study.

Ming-Sound Tsao, Kazuhiro Yasufuku, Christian Couture, 2015, Chest.

Influence of trainee involvement on procedural characteristics for linear endobronchial ultrasound

S. Martel, F. Laberge, N. Lampron, 2017, Thoracic cancer.

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

Paul Kearney, Anil Vachani, Pierre P. Massion, 2018, Chest.

Blood hypereosinophilia in the course of posttraumatic pleural effusion.

F. Maltais, Y. Cormier, F. Laberge, 1990, Chest.

Probability of cancer in pulmonary nodules detected on first screening CT.

S. Lam, C. Berg, A. Tremblay, 2013, The New England journal of medicine.